Progestins in breast cancer treatment. A review. - Wikidata - wikimedia - TriplyDB

Progestins in breast cancer treatment. A review.

Progestins in breast cancer treatment. A review.

http://www.wikidata.org/entity/Q35651439

about

Additive endocrine therapy for advanced breast cancer - back to the future.Evolution of endocrine adjuvant therapy for early breast cancer.Emerging drugs in metastatic breast cancer

P2860

Q37622884-BE6484CE-73AF-4148-AE7A-EA087ACAF7CD Q37725970-0A8233ED-D6D9-48AA-934F-435857BC690B Q57142532-29A815F9-1C48-43C9-821F-C761B53F93C5

P2860

Progestins in breast cancer treatment. A review.

http://www.wikidata.org/entity/Q35651439

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Progestins in breast cancer treatment. A review.

@ast

Progestins in breast cancer treatment. A review.

@en

type

label

Progestins in breast cancer treatment. A review.

@ast

Progestins in breast cancer treatment. A review.

@en

prefLabel

Progestins in breast cancer treatment. A review.

@ast

Progestins in breast cancer treatment. A review.

@en

P1433

Q35651439-F7348618-DFE3-4DFD-AF20-06EF28D88AF6

P1476

Q35651439-F71BEFE1-73C6-4D50-AF66-A178650C7F6A

P2860

Q35651439-10D78D14-F44E-4255-AE3A-B4951F9A9979

Q35651439-11D86FBF-7B42-43B1-BAD2-149DC17609A8

Q35651439-2427F047-9B56-4350-AC39-D5AB16B14903

Q35651439-3564AA79-87A1-4DA5-911B-67CD740FD719

Q35651439-3D2869C2-C5AD-40C2-B085-6B97CE3F4EEE

Q35651439-4FD6150C-E68D-4A9C-8545-FFB39D3E822D

Q35651439-5387A4AD-76DC-4BB2-BAA5-9ADB24B18FFC

Q35651439-5A09CB7F-AD91-4BB4-AD95-13268341545E

Q35651439-6017D9C8-D3CD-415C-A5B5-9473B59F4B37

Q35651439-617E38BA-0E92-43C4-B40B-0B9E995486A9

P304

Q35651439-92C30C6F-DAE0-4B66-B791-967CBBD9BF62

P31

Q35651439-94E1CFE6-B5E7-4EAE-973D-68DA11BFCE5D

P356

Q35651439-8AE414ED-1214-41F8-AA96-8897498E18A9

P433

Q35651439-CFA7D59A-BE51-4E84-9118-0305C9178F67

P478

Q35651439-0068F9FD-49CB-42C8-96CB-1BF9D9942725

P50

Q35651439-B5C8BC32-BCC8-4CE2-BE5E-9469FE148C62

P577

Q35651439-034F0A83-540F-40D6-B4D7-BC43634A52E9

P5875

Q35651439-B50B2396-9167-4064-9B6F-1F8425922360

P698

Q35651439-A7D6A75E-93E6-4FE1-9C0C-A9C51D120E6D

P356

02841869209083859

P1433

Acta Oncologica

P1476

Progestins in breast cancer treatment. A review.

@en

P2860

A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474

Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels

The pharmacology and clinical uses of tamoxifen

Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--I. General findings

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630

The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.

Effects of endocrine therapy on steroid-receptor content of breast cancer.

Assessment of response to therapy in advanced breast cancer.

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer

P304

709-722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02841869209083859

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Steinar Lundgren

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232050229

http://www.w3.org/2001/XMLSchema#string

P698

1476750

http://www.w3.org/2001/XMLSchema#string